CPL, INC. v. Fragchem Corp.

512 F.3d 389, 69 Fed. R. Serv. 3d 1262, 2008 U.S. App. LEXIS 320, 2008 WL 80637
CourtCourt of Appeals for the Seventh Circuit
DecidedJanuary 9, 2008
Docket07-1784
StatusPublished
Cited by8 cases

This text of 512 F.3d 389 (CPL, INC. v. Fragchem Corp.) is published on Counsel Stack Legal Research, covering Court of Appeals for the Seventh Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
CPL, INC. v. Fragchem Corp., 512 F.3d 389, 69 Fed. R. Serv. 3d 1262, 2008 U.S. App. LEXIS 320, 2008 WL 80637 (7th Cir. 2008).

Opinion

FLAUM, Circuit Judge.

CPL and Fragchem do business in the chemicals industry, but their commercial chemistry is now questionable. The two companies began their relationship under an exclusive Supply Agreement, terminated this agreement years later, and then resumed conducting transactions soon thereafter. In April of 2004, Fragchem received a shipment of chemicals from CPL but refused to submit payment. CPL filed a complaint with the district court, and Fragchem responded by filing a motion to dismiss under Federal Rule of Civil Procedure 12(b)(7) for failure to join a necessary party. Instead of deciding this motion on the merits, the district court dismissed the lawsuit sua sponte on the basis of improper venue on the grounds that the Supply Agreement between the two parties contained an agreement to arbitrate. For the reasons set forth in this opinion, we reverse the ruling of the district court.

I. Background

CPL is a corporation engaged in the sale of chemicals used in the manufacture of generic pharmaceutical products. It is organized under the laws of Missouri, with its principal place of business in Gaithers-burg, Maryland. Its parent company, Ca-dila, is registered under the Indian Companies Act, conducting business under the laws of India with its Registered Office located in Ahmedabad, Gujarat, India. This case arises out of a dispute between Cadila/CPL and Fragchem, a corporation that is engaged in the import and export of chemicals. Fragchem is organized under the laws of Illinois with its principal place of business in Niles, Illinois.

On May 9, 1997, Cadila and Fragchem entered into an exclusive Supply Agreement. Under the terms of this agreement, Cadila was required to manufacture and supply certain chemicals exclusively to Fragchem, in exchange for which Fragch-em was to transfer details of the processes and technical data to enable Cadila to develop and manufacture those chemicals. In particular, Fragchem provided technical specifications, the general process for manufacturing Chlorhexidine Base, Chlorhexi-dine HCL, and Chlorhexidine Gluconate 20% solution (the “C Products”), information regarding raw materials, and processing details. Cadila’s end of the deal was that it agreed to manufacture and supply C Products exclusively for Fragchem using the information and technology it supplied. The Supply Agreement also stipulated that Fragchem was to purchase C Products exclusively from Cadila.

Several months after the agreement was signed, Cadila began shipping C Products to Fragchem. Fragchem initially made its payments directly to Cadila, but in 2000, Cadila informed Fragchem that it should start submitting purchase orders and payments for C Products to its subsidiary, *391 CPL, which it indicated was also bound by the terms of the Supply Agreement. Fragchem ultimately agreed to submit its subsequent payments to CPL.

The Supply Agreement, which is at the heart of this case, contained an agreement to arbitrate that read:

Any controversy arising under this Agreement, or any breach thereof, shall be referred to and finally settled pursuant to Arbitration in accordance with the provisions of Arbitration and Conciliation Proceedings prevalent in India, and judgment upon this award may be entered in any court having jurisdiction. However, such Arbitration proceedings shall take place in Ahmedabad (Gujarat) in India and the language of such arbitration shall be English.

In addition, with respect to amendment and assignment, the Supply Agreement provided as follows:

The agreement may not be amended, waived, discharged, or terminated orally, but only by an instrument in writing signed by the party against which enforcement ... is sought. This agreement shall be binding upon the respective parent, subsidiaries, affiliates, successors, and assigns of CPL and Fragchem. This agreement may not be assigned by any party without the written consent of the other parties.

The Supply Agreement itself had an initial term of five years, and could be terminated upon written notice given at least 180 days before expiration of the initial five-year term. In accordance with this provision, Cadila gave Fragchem written notice on November 7, 2001 that it was terminating the supply agreement effective May 8, 2002. Fragchem acknowledged this termination by letter dated May 6, 2002:

By your notice of termination dated November 7, 2001, you have expressed your will to terminate the above referred supply agreement at the end of the first contract period ending by May 8, 2002.... Now that through your notice referred above, our above referred understanding “agreement” will come to an end....

This same letter also admonished CPL that it “... shall not manufacture and/or sell Chlorhexidine Base and its salts after May 8, 2002....”

In an about-face one month later, on June 3, 2002, Fragchem’s Secretary, Kirit Parikh, sent another letter to Cadila’s chairman:

I am confident that we will soon reach a new agreement to serve as the basis for moving forward for the benefit of all parties involved. Until that time, let’s do business just as we had been doing prior to the termination of the Supply Agreement.

There is no evidence of a written response from CPL, though Parikh submitted an affidavit that indicates that it is his belief that Cadila and Fragchem agreed to continue doing business under the Supply Agreement.

Regardless, Fragchem and CPL continued to do business from June 2002 to March 2004. Fragchem contends that these deals were done pursuant to the Supply Agreement. CPL contends that these purchases were made on an individualized basis, sometimes pursuant to a written purchase order from Fragchem, and more often orally. CPL asserts that to the extent that these purchases were made pursuant to any identifiable agreement, it would have been their standard terms and conditions form, which states:

All sales are subject to and expressly conditioned upon the terms and conditions contained herein. No variation of these terms and conditions will be bind *392 ing upon seller unless agreed to in writing by an authorized representative of seller.

Notably, CPL’s' standard terms and conditions form does not contain an arbitration provision.

In April of 2004, Fragchem placed an order for 4,000 kilograms of CH Base from CPL. 1 Fragchem disputes that it had actually placed the April order, but admits that it received the product and never paid the $131,000 owed to CPL. The record reflects that Fragchem has withheld payment from CPL because it believes that Cadila owes it commissions for C Product sales made by Cadila to other customers.

In response, CPL filed a complaint against Fragchem on March 10, 2006, asserting claims for breach of contract arising out of Fragchem’s failure to make payment after the April delivery. Fragch-em countered by filing a motion to dismiss pursuant to Federal Rule of Civil Procedure

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Nucap Industries, Inc. v. Robert Bosch LLC
273 F. Supp. 3d 986 (N.D. Illinois, 2017)
TicketNetwork, Inc. v. Darbouze
133 F. Supp. 3d 442 (D. Connecticut, 2015)
Kay v. Board of Educ. of City of Chicago
547 F.3d 736 (Seventh Circuit, 2008)
Cynthia M. Banks v. United States
614 F.2d 95 (Sixth Circuit, 1980)

Cite This Page — Counsel Stack

Bluebook (online)
512 F.3d 389, 69 Fed. R. Serv. 3d 1262, 2008 U.S. App. LEXIS 320, 2008 WL 80637, Counsel Stack Legal Research, https://law.counselstack.com/opinion/cpl-inc-v-fragchem-corp-ca7-2008.